Illumina, Inc.

NASDAQ:ILMN

Medical - Diagnostics & Research

Healthcare
$210.01 +1.23%

+$1.95 today

Market cap
$31.75B
Beta
1.49
P/E (TTM)
28.9
EPS (TTM)
$5.58
52W Low $88.00High $177.22

Volume 1.63M

Average 1.65M

ILMN Net Debt

Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.

Illumina, Inc.NASDAQ: ILMN

Net Debt · Q2 FY2026 · quarter ended Jun 2026

Net debt falls 10.6% from a year ago

Net debt stood at $1.49B at the end of Q2 FY2026, down 10.6% from a year earlier and up 2.2% from the prior quarter. Over 3 fiscal years it compounded at -9.7% a year.

Context

  • Net debt amounted to 22.4% of total assets at the end of Q2 FY2026, down 5.0 pp from a year earlier.
  • Net debt increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net debt keeps falling in the next quarterly balance sheet after a -10.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1.49B+2.2% QoQ
Last fiscal yearDec 2025
$1.14B-24.1% YoY
Year agoJun 2025
$1.66B-10.6% since
Net Debt past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-10.6%——
1 year-24.1%——
3-year CAGR-9.7%——
5-year CAGR——
10-year CAGR——

Net Debt history

USD · from the balance sheet

Latest · FY2025
1.14B USD
Year-over-year change
-24.1%
4-year CAGR
-3.5%

Net Debt vs competitors

How ILMN compares with its peers on the latest reported figures

  • ILMN's Jun 2026 net debt of $1.49B is the highest of the 11 companies compared; the peer median is $42.07M.
  • Its year-over-year change of -10.6% is the 7th highest of 11, against a peer median of -2.5%.
  • Net debt amounts to 22.4% of total assets for ILMN, versus a peer median of 27.2%.
ILMN Competitors Peer median
Net Debt for ILMN and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
ILMNIllumina, Inc.Jun 2026$1.49B -10.6%-9.7%22.4%
GHGuardant Health, Inc.Sep 2026$664.59M -11.0%+2.8%35.2%
PACBPacific Biosciences of California, Inc.Mar 2026$647.1M +1.0%+3.7%82.7%
NEONeoGenomics, Inc.Jun 2026$302.83M +17.8%-3.5%22.4%
WGSGeneDx Holdings Corp.Jun 2026$107.09M +166.0%—22.2%
MYGNMyriad Genetics, Inc.Mar 2026$87.1M +32.4%-11.9%12.9%
SOPHSOPHiA GENETICS S.A.Mar 2026-$2.97M +92.3%—1.9%
PSNLPersonalis, Inc.Mar 2026-$34.81M -31.0%—10.7%
BLLNBillionToOne, Inc.Jun 2026-$404.71M -392.1%—55.5%
TXG10x Genomics, Inc.Sep 2026-$450.4M -67.4%—42.4%
NTRANatera, Inc.Jun 2026-$853.01M -6.1%—32.1%
Peer median (excluding ILMN) $42.07M-2.5%-0.4%27.2%

Competitors are the stored peer set for ILMN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Jan 2022
FY2022
Jan 2023
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents1.23B2.01B1.05B1.13B1.42B
Short-term Investments107M26M6M93M215M
Net Receivables664M688M752M751M854M
Inventory431M568M587M547M564M
Other Current Assets0268M216M228M238M
Total Current Assets2.71B3.56B2.61B2.75B3.29B
Property, Plant & Equipment (Net)1.7B1.74B1.55B1.23B1.13B
Goodwill7.11B3.24B2.55B1.11B1.11B
Intangible Assets3.25B3.29B2.99B295M210M
Long-term Investments213M211M196M227M338M
Tax Assets000567M454M
Other Non-current Assets232M212M217M121M111M
Total Non-current Assets12.5B8.69B7.5B3.56B3.36B
Total Assets15.22B12.25B10.11B6.3B6.64B
Account Payables332M293M245M221M240M
Short-term Debt01.25B0578M499M
Tax Payables98M97M79M101M0
Deferred Revenue234M245M252M260M270M
Other Current Liabilities241M188M223M70M249M
Total Current Liabilities1.09B2.77B1.57B1.55B1.59B
Long-term Debt1.7B1.49B1.49B1.49B1.49B
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00067M0
Other Non-current Liabilities915M649M620M272M360M
Total Non-current Liabilities3.38B2.88B2.8B2.38B2.34B
Total Liabilities4.48B5.65B4.37B3.93B3.92B
Common Stock2M2M2M2M2M
Retained Earnings5.49B1.14B(19M)(1.24B)(392M)
Accumulated OCI17M3M(1M)22M(10M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity10.74B6.6B5.75B2.37B2.72B
Total Debt2.54B3.56B2.26B2.62B2.55B
Net Debt1.31B1.54B1.21B1.5B1.14B

Illumina, Inc.

NASDAQ:ILMN

Intrinsic Alpha fair value

Locked

Current Price

$210.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.